ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NASDAQ share market NEWS tomorrow (08 July, 2021). NASDAQ stocks in NEWS (tomorrow)

NASDAQ share market NEWS tomorrow (08 July, 2021). NASDAQ stocks in NEWS (tomorrow) These are NASDAQ stocks which will be in NEWS tomorrow as on 08 July 2021

Celldex Therapeutics was amongst the top gainers, currently trading at 31.04 in NASDAQ with 0.813 times change in volumes and 7.219% change in price. Other gainers included Biogen Inc with 3.861% price change and 1.702 times volumes, Ziopharm Oncology with 3.252% price change and 0.962 times volumes, Amicus Therapeutics with 2.961% price change and 1.193 times volumes, and Arrowhead Pharmaceuticals with 2.495% price change and 0.609 times volumes. These stocks are expected to continue this move in coming days also. You can take a position in these stocks tomorrow and hold the position for a few days with today's opening as stoploss.

Csx Corporation was amongst the top losers, currently trading at 30.95 in NASDAQ with 1.925 times change in volumes and -6.155% change in price. Other losers included Avis Budget with -5.984% price change and 1.56 times volumes, 21vianet Group with -5.433% price change and 1.024 times volumes, Endo International with -4.872% price change and 1.007 times volumes, and Canadian Solar with -4.065% price change and 0.763 times volumes. These stocks are expected to continue this move in coming days also. You can take a position in these stocks tomorrow and hold the position for a few days with today's opening as stoploss.

Other stocks which made news headlines today and can be traded tomorrow are below.

Thursday shaping up as worst day in months for U.S. stocks. Thursday shaping up as worst day in months for U.S. stocks

Japan's new state of emergency means no spectators for Summer Olympics. Japan's new state of emergency means no spectators for Summer Olympics

U.S. mortgage rates hit lowest levels since winter. U.S. mortgage rates hit lowest levels since winter

Chobani files confidentially for IPO. Chobani files confidentially for IPO

Coronavirus Daily: Study concludes vaccines will save 279,000 U.S. lives in 2021. Coronavirus Daily: Study concludes vaccines will save 279,000 U.S. lives in 2021

Dow down 225 points even as Thursday stock-market declines are halved. Dow down 225 points even as Thursday stock-market declines are halved

Bad Friday? A 'death cross' in Tesla's stock chart is coming at week's end. Bad Friday? A 'death cross' in Tesla's stock chart is coming at week's end

Dow ends down over 260 points as stocks retreat from records on growth concerns. Dow ends down over 260 points as stocks retreat from records on growth concerns

Dow futures tumble over 300 points as bond rally continues. Dow futures tumble over 300 points as bond rally continues

European Central Bank unveils new policy strategy. European Central Bank unveils new policy strategy

Need to Know: What economists attribute the ongoing bond-yield plunge to. Need to Know: What economists attribute the ongoing bond-yield plunge to

Coming at 8:30 a.m.: Latest data on new and continuing unemployment claims. Coming at 8:30 a.m.: Latest data on new and continuing unemployment claims

All 30 components of DJIA have sustained premarket losses on Thursday. All 30 components of DJIA have sustained premarket losses on Thursday

Chipotle says it's now accepting résumés submitted on TikTok. Chipotle says it's now accepting résumés submitted on TikTok

Weekly U.S. initial jobless claims rise to 373,000 in early July. Weekly U.S. initial jobless claims rise to 373,000 in early July

Walgreens same-day prescription delivery expanded to nearly all U.S. stores. Walgreens same-day prescription delivery expanded to nearly all U.S. stores

Dow futures now indicate 500-point Thursday decline as bond rally continues. Dow futures now indicate 500-point Thursday decline as bond rally continues

S&P 500 joins Nasdaq Composite in notching all-time highs early Wednesday. S&P 500 joins Nasdaq Composite in notching all-time highs early Wednesday

Moderna launches Phase 1/2 trial for experimental flu vaccine. Moderna launches Phase 1/2 trial for experimental flu vaccine

Amtrak says .3 billion equipment investment will ‘transform’ rail travel. Amtrak says .3 billion equipment investment will ‘transform’ rail travel

Stock gains pared as May data show U.S. job openings rising to 9.2 million. Stock gains pared as May data show U.S. job openings rising to 9.2 million

CDC says delta variant is now responsible for a majority of U.S. COVID-19 cases. CDC says delta variant is now responsible for a majority of U.S. COVID-19 cases

Coronavirus Update: Delta cases most prevalent in Kansas City and Denver regions. Coronavirus Update: Delta cases most prevalent in Kansas City and Denver regions

The 'black swan' index hit a record high. Here's what that means for stocks. The 'black swan' index hit a record high. Here's what that means for stocks

Apple stock is on track for its first record-high close since January. Apple stock is on track for its first record-high close since January

S&P 500, Nasdaq Composite finish at record highs. S&P 500, Nasdaq Composite finish at record highs

EU revises up growth expectations for 2021, 2022 on pandemic progress. EU revises up growth expectations for 2021, 2022 on pandemic progress

Haiti's president assassinated, according to interim premier. Haiti's president assassinated, according to interim premier

Need to Know: Economist sees the West heading for a ‘very drastic crisis’. Need to Know: Economist sees the West heading for a ‘very drastic crisis’

10-year Treasury yield plunges below 1.30%; 30-year yield under 2%. 10-year Treasury yield plunges below 1.30%; 30-year yield under 2%

Dow industrials pointing toward decline at opening bell as bond yields fall. Dow industrials pointing toward decline at opening bell as bond yields fall

AMC's stock on rise after withdrawal of request to issue new shares. AMC's stock on rise after withdrawal of request to issue new shares

Israel says Pfizer vaccine is 64% effective against delta-variant infections. Israel says Pfizer vaccine is 64% effective against delta-variant infections

Biden to provide update Tuesday afternoon on virus and vaccinations. Biden to provide update Tuesday afternoon on virus and vaccinations

ISM data suggest shortages and worker scarcity cooling economy's service sector. ISM data suggest shortages and worker scarcity cooling economy's service sector

Tuesday stock-market declines steepen in wake of ISM service-sector data. Tuesday stock-market declines steepen in wake of ISM service-sector data

Death toll at Surfside, Fla., condominium rises to 32. Death toll at Surfside, Fla., condominium rises to 32

Coronavirus Update: Russia and Indonesia report record one-day death tolls. Coronavirus Update: Russia and Indonesia report record one-day death tolls

Pentagon cancels billion JEDI contract that pitted Amazon against Microsoft. Pentagon cancels billion JEDI contract that pitted Amazon against Microsoft

Nasdaq ekes out record as Dow drops 200 points, S&P snaps winning streak. Nasdaq ekes out record as Dow drops 200 points, S&P snaps winning streak

Amazon stock ends at record as JEDI deal gets canceled on new CEO’s first day. Amazon stock ends at record as JEDI deal gets canceled on new CEO’s first day

Didi Global shares slammed in premarket trade after Chinese crackdown. Didi Global shares slammed in premarket trade after Chinese crackdown

Mercedes-Benz says chip shortage to weigh on sales in second half. Mercedes-Benz says chip shortage to weigh on sales in second half

Latest stock market News for tomorrow Access previous news reports: 1177117811791180118111821183118411851186118711881189119011911192119311941195

Videos related to: NASDAQ share market NEWS tomorrow (08 July, 2021). NASDAQ stocks in NEWS (tomorrow)

Hindi Video How To Be Successful Share Market Rich Like Jhunjhunwala, Vijay Kadia. Exact Steps!

Hindi Basics How To Trade In FnO Futures Options Stock Market

NASDAQ share market NEWS tomorrow (08 July, 2021). NASDAQ stocks in NEWS (tomorrow)

 

Back to top